Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23862,191,0.68 [0.48-0.95],0.0253343376062531
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23617,1423,0.87 [0.76-0.99],0.0295607881620504
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Candidiasis,23876,380,0.76 [0.60-0.97],0.0302917564857006
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23181,3493,0.87 [0.80-0.94],0.0005396441507695
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23138,3508,0.90 [0.83-0.98],0.0116027660041194
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20884,1248,0.82 [0.72-0.94],0.0048238604450451
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16800,2285,0.85 [0.77-0.94],0.0013508834134579
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Mycoses,23968,472,0.78 [0.63-0.97],0.0240469279675272
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23095,901,0.85 [0.72-0.99],0.0403793461814342
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22800,193,0.66 [0.47-0.93],0.0171931444350005
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22482,288,0.71 [0.54-0.94],0.0184941167288193
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23953,144,0.58 [0.39-0.87],0.0075475921004418
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral warts,23861,52,0.40 [0.21-0.76],0.0052792260251698
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Lung cancer and mesothelioma,15981,344,0.57 [0.44-0.73],1.177474833026344e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18801,219,0.65 [0.48-0.88],0.0061789458608926
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22262,118,0.62 [0.40-0.96],0.0326075282550483
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23441,2793,0.85 [0.78-0.93],0.0004994956086537
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23580,53,2.25 [1.18-4.29],0.0138847765274641
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23625,1481,0.79 [0.70-0.89],0.0001726842725702
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23623,1479,0.79 [0.70-0.89],0.0002002877204882
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23765,1102,0.81 [0.70-0.94],0.0044377164667573
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23842,315,1.44 [1.10-1.88],0.008600684860986
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23910,48,2.48 [1.28-4.79],0.0070901715648998
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23783,256,1.40 [1.04-1.89],0.0276734629872664
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17387,58,0.40 [0.22-0.73],0.00284764768664
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17402,73,1.97 [1.12-3.47],0.0183554008555917
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21230,3901,0.78 [0.72-0.84],3.4539928574948016e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17517,188,0.53 [0.38-0.75],0.0003139387193202
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17485,156,0.67 [0.46-0.98],0.0377874473177873
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",18063,734,0.71 [0.59-0.85],0.0001464517794238
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,17475,146,0.63 [0.42-0.93],0.0214842908580865
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17899,570,0.60 [0.49-0.73],5.942652117948082e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17724,395,0.69 [0.54-0.87],0.0020136859490151
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21683,70,0.53 [0.30-0.92],0.0243316628188801
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22557,5228,0.79 [0.74-0.84],4.069070392195499e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23832,1797,0.85 [0.76-0.95],0.0057473197440949
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23829,1793,0.85 [0.76-0.95],0.0054626988189334
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18957,1628,0.72 [0.64-0.81],6.061749012307775e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2530,124,1.62 [1.06-2.47],0.0245953294024576
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23215,2189,0.63 [0.57-0.70],4.961662094511595e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,18135,806,0.68 [0.58-0.81],8.938085213981377e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22771,273,0.66 [0.50-0.88],0.0046070379207361
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Angina pectoris,21064,1504,0.76 [0.67-0.86],2.1245939008496167e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cardiac arrest,11981,251,0.73 [0.54-0.98],0.0393633631327163
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Conduction disorders,20047,1375,0.87 [0.77-1.00],0.0423627145133289
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22185,2649,0.84 [0.76-0.92],0.0002406864095316
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20219,7823,0.82 [0.78-0.86],6.312781272019947e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertension,21423,6811,0.79 [0.74-0.83],8.4386782790112595e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21447,6835,0.79 [0.74-0.84],1.1540575265752717e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14798,186,0.62 [0.44-0.88],0.0071745956252496
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14783,171,0.65 [0.45-0.94],0.0213579735376342
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypotension,23859,1246,0.86 [0.75-0.98],0.0276265049999741
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22324,2764,0.84 [0.76-0.92],0.000130312000411
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23572,659,0.76 [0.63-0.91],0.0031445126305415
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23272,1071,0.83 [0.72-0.96],0.0146026898775049
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22780,282,0.71 [0.54-0.94],0.0179409153172847
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22987,674,0.76 [0.63-0.91],0.0034950380085215
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23556,746,0.78 [0.66-0.93],0.0057770761086858
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23540,775,0.79 [0.66-0.93],0.0059833876285118
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23163,250,0.69 [0.51-0.94],0.0171975256903002
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22519,318,0.67 [0.52-0.88],0.0038478854546407
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Any mental disorder,23312,3648,0.84 [0.78-0.91],1.3990169306127176e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20846,1182,0.86 [0.75-0.99],0.0338409358500787
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Smoking dependency,23360,1541,0.69 [0.62-0.78],2.330950586236281e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21543,1879,0.75 [0.68-0.83],2.1466382211993644e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23987,73,0.49 [0.28-0.85],0.0112646057365313
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23463,1379,0.84 [0.74-0.95],0.0078190921376618
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Hydrocephalus,23417,55,0.50 [0.27-0.93],0.0291562133926342
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Neurological diseases,22675,3702,0.88 [0.82-0.96],0.0021452138869758
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23679,242,0.73 [0.54-1.00],0.0466299312726163
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23518,156,0.54 [0.37-0.79],0.001573103076397
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other neurological diseases,23888,526,0.76 [0.62-0.93],0.008850523111047
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other sleep disorders,22794,710,0.76 [0.63-0.91],0.0027531343405534
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Sleep apnoea,23700,640,0.79 [0.65-0.95],0.0136876329463051
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23613,59,2.06 [1.11-3.81],0.0218189515663004
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23806,293,0.66 [0.50-0.88],0.003743994814948
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3030,132,1.80 [1.20-2.70],0.0041441360255306
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23700,619,0.81 [0.67-0.99],0.0361439203601456
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23166,85,0.58 [0.35-0.97],0.0382253873295564
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23911,681,0.83 [0.69-0.99],0.0413259877207474
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23690,460,0.73 [0.59-0.91],0.0059876281817149
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22625,1805,0.84 [0.75-0.94],0.0026770137371349
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23500,419,0.78 [0.62-0.98],0.0348254131659757
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22300,1480,0.86 [0.76-0.98],0.0209754237530066
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23913,979,0.78 [0.67-0.91],0.0015902447245896
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23661,727,0.84 [0.70-1.00],0.048928724341027
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16737,1451,0.87 [0.77-0.99],0.0289343635475347
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17061,1424,0.86 [0.76-0.98],0.0244210896472491
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Bronchiectasis,20868,289,0.65 [0.49-0.86],0.0028312666665636
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23151,2572,0.81 [0.74-0.89],8.764694920088829e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23782,1307,0.72 [0.63-0.82],4.253817876440484e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Deviated nasal septum,22615,141,0.59 [0.40-0.88],0.0089631219508578
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21983,5316,0.90 [0.84-0.96],0.0020437571321358
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22866,392,0.70 [0.55-0.89],0.0033241320212255
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Early onset COPD,22784,309,0.51 [0.40-0.66],2.045747801527437e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Emphysema,20930,351,0.55 [0.43-0.70],1.5247987809133565e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23069,342,0.43 [0.33-0.56],9.564865907345083e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23757,2163,0.82 [0.74-0.91],0.0002017561478769
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Interstitial lung disease,23097,370,0.47 [0.37-0.61],2.553346098476474e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Later onset COPD,22930,998,0.78 [0.68-0.91],0.0013780809020166
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of pleura,23724,2208,0.87 [0.79-0.96],0.0066534322723865
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23911,454,0.58 [0.46-0.72],1.117186126113307e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23883,1396,0.85 [0.75-0.97],0.0141043459034223
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural plaque,21781,265,0.72 [0.54-0.97],0.0287921562414747
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23491,1897,0.83 [0.75-0.93],0.0010830016794633
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pneumothorax,21658,142,0.60 [0.41-0.89],0.0103673504800821
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Viral pneumonia,21878,284,0.72 [0.54-0.95],0.0219693943392254
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23635,241,0.70 [0.52-0.95],0.023916796734762
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Constipation,23842,1607,0.84 [0.74-0.94],0.0033598513678014
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn disease,22603,93,0.47 [0.29-0.76],0.0019486257386631
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22588,78,0.51 [0.30-0.86],0.0114090188652071
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Dental caries,23357,227,0.73 [0.54-1.00],0.0487319306400779
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20324,1957,0.90 [0.80-1.00],0.0471289849875632
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21993,3967,0.91 [0.84-0.98],0.0171156641251988
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23688,1418,0.85 [0.75-0.96],0.010341912657084
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19742,3068,0.84 [0.77-0.92],0.0001381703671949
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23890,211,0.71 [0.51-0.98],0.0355208254197479
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastric ulcer,18395,369,0.77 [0.60-0.99],0.0423150530694
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18628,602,0.77 [0.63-0.93],0.0079486777109035
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18358,8048,0.94 [0.89-1.00],0.0356410847595313
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestines,22180,5506,0.89 [0.83-0.95],0.0004383671207616
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18772,746,0.77 [0.65-0.92],0.0037986545786674
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18319,1645,0.82 [0.73-0.92],0.0009517128846719
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19909,1883,0.90 [0.80-1.00],0.0494294768981901
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17154,480,0.79 [0.63-0.98],0.0348698897072144
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22436,166,0.62 [0.43-0.89],0.0093093679456568
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18324,298,0.71 [0.54-0.94],0.0152577455344481
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22702,203,0.65 [0.47-0.90],0.0098560173109105
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23917,476,0.78 [0.63-0.97],0.0275218847742064
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20488,3397,0.90 [0.83-0.98],0.0165867967870178
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20433,6310,0.94 [0.88-1.00],0.0348359428308105
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20691,53,0.51 [0.27-0.97],0.0387860001925984
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18569,1478,0.88 [0.77-1.00],0.0441505610881608
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18085,994,1.21 [1.04-1.41],0.0144576412941053
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23867,980,1.22 [1.04-1.42],0.0125579227154185
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17726,635,1.33 [1.10-1.61],0.003528344231943
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17685,594,1.30 [1.07-1.59],0.0089537390643017
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20704,66,0.49 [0.28-0.87],0.0150995635300013
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),17132,41,2.30 [1.09-4.85],0.0285476198071426
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21547,620,0.77 [0.64-0.94],0.0087520230155318
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18309,1218,0.82 [0.71-0.94],0.0044727893992584
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21040,113,0.46 [0.30-0.72],0.0006760196264509
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23992,39,0.44 [0.21-0.91],0.0273275044261099
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19687,578,0.78 [0.64-0.95],0.0135378556177895
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23993,40,0.38 [0.18-0.77],0.0078124834926721
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21437,510,0.79 [0.64-0.98],0.0342321776983486
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22939,200,0.57 [0.41-0.80],0.0011548448171964
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23752,86,1.97 [1.18-3.30],0.0094234590979095
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Dialysis,21220,106,1.89 [1.19-2.99],0.0068780011880164
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21612,5624,0.94 [0.88-1.00],0.0435246534247399
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20921,75,0.44 [0.26-0.76],0.0030817355989666
